14
Nov
Sanofi Consumer Healthcare India Limited (BSE: 544250 | NSE: SANOFICONR) has reported robust financial results for the third quarter of FY2025, with revenue surging 46% year-on-year to ₹2,339 million and net profit rising 40% to ₹629 million. The growth was driven by a sharp rebound in exports and steady domestic sales. Export sales grew more than tenfold during the quarter owing to a low base, while domestic sales recorded a 20% increase. For the nine-month period, the company posted revenue of ₹6,274 million, up 13% year-on-year, with profit after tax increasing by 27%. Himanshu Bakshi, Managing Director, Sanofi Consumer Healthcare…
